Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer using GFR α-4 chimeric antigen receptor

Treatment of cancer using GFR α-4 chimeric antigen receptor

US Patent 10851149 · Granted Dec 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for retrieving tumor-related antibodies and antigens2025
Antibody compounds with reactive arginine and related antibody drug conjugates2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Methods for improving the efficacy and expansion of immune cells2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Method of redirecting t cells to treat HIV infection2024
Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated pr2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024